KB
Kajal Biswas
Research areas: Biochemistry, Genetics and Molecular Biology · Genetics · BRCA gene mutations in cancer · DNA Repair Mechanisms · PARP inhibition in cancer therapy
0000-0003-2645-9349
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Rare cancers research: current state of knowledge and emerging opportunities for prevention and interception Save
- Yes, It Is Worth It: Consider Participant Experiences in the Design of Future Trials Save
- Green Cancer Prevention and Beyond Save
- Genetically engineered mouse models for hereditary cancer syndromes Save
- Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma. Save
- BRCA2-DSS1 interaction is dispensable for RAD51 recruitment at replication-induced and meiotic DNA double strand breaks Save
- A novel mouse model of PMS2 founder mutation that causes mismatch repair defect due to aberrant splicing Save
- Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer Save
- Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2) Save
- WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells Save
- A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays Save
- Bypass of premature stop codons and generation of functional BRCA2 by exon skipping Save
- Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay Save
- RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers Save
- BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage Save
- Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption Save
- Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect Save
- BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation Save
- Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies Save
- Cripto-1 as a novel therapeutic target for triple negative breast cancer Save